Can pancreatic tumor cancer be controlled with medication?

Generally, pancreatic cancer can be controlled with medication. The detailed analysis is as follows:

Pancreatic cancer is a malignant tumor originating from the epithelial cells of the pancreatic ducts and acinar cells. Currently, several targeted and immunotherapy drugs have been approved for the treatment of pancreatic cancer, such as erlotinib hydrochloride tablets, everolimus tablets, and sunitinib malate capsules. These medications target specific genotypes or tumor markers and work by blocking the growth and survival signals of cancer cells, thereby controlling tumor progression.

However, different patients may respond very differently to the same drug. For certain highly aggressive or rapidly progressing types of pancreatic cancer, even combined treatment with multiple drugs may struggle to effectively control the disease, as these tumors often exhibit low sensitivity to medications. Additionally, when pancreatic cancer has extensively metastasized to other organs, it becomes difficult for drugs to completely eliminate all metastatic sites, and the effectiveness of treatment declines significantly.

Patients are advised to maintain a positive attitude, follow a balanced diet, and engage in appropriate physical activity, all of which can help improve treatment outcomes and quality of life.